KVP Capital Advisors’s Soleno Therapeutics SLNO Stock Holding History

KVP Capital Advisors’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-59,700	Closed	-$2M	–	37
2026 Q1	$2M	Hold	59,700	–	–	1.49%	26
2025 Q4	$2.76M	Buy	+59,700	New	+$3.27M	2.67%	15

KVP Capital Advisors's SLNO Position: Q2 2026 in Review

KVP Capital Advisors sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 59,700 shares — an estimated $2M sold.

KVP Capital Advisors first reported a position in SLNO in Q4 2025 and held it in 2 quarters. The position peaked at $2.76M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

KVP Capital Advisors reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
KVP Capital Advisors sold 59,700 Soleno Therapeutics shares in Q2 2026, an estimated $2M.
KVP Capital Advisors first reported a position in Soleno Therapeutics in Q4 2025 and held it in 2 quarters.
KVP Capital Advisors's Soleno Therapeutics position peaked at $2.76M in Q4 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on KVP Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.